Sema4 has named William K. Oh, M.D., to the newly established senior leadership position of Chief Medical Science Officer.
Dr. Oh, who was previously Chair of Sema4’s Scientific Advisory Board for Oncology, is an internationally recognized medical oncologist with over 25 years of clinical and translational research experience and leadership roles at major NCI-designated cancer centers at Harvard and Mount Sinai.
“We are privileged to have a world-renowned oncologist of William’s stature join the Sema4 team. His deep clinical expertise will help us further establish our leadership in delivering data-driven precision oncology solutions that support improved patient outcomes,” said Eric Schadt, PhD, Founder and Chief Executive Officer of Sema4.